"While The Use Of Endovascular Therapy Doubled With The Emergence Of The “Endovascular Era”, It Remains Underutilized"
According to researchers at the Icahn School of Medicine at Mount Sinai, patients admitted with acute ischaemic stroke were twice as likely to receive endovascular therapy beyond February 2015—or what the authors have classed as the emergence of the “endovascular era”—as compared to the months prior. “This may reflect presentation and treatment of acute ischaemic stroke patients eligible for treatment beyond 4.5 hours from last known well,” said Laura Stein, MD, assistant professor of neurology at the Icahn School of Medicine at Mount Sinai. She added, “Such choices would be counter to current AHA/ASA guidelines.”
— Laura K. Stein, MD, Assistant Professor, Neurology, Icahn School of Medicine at Mount Sinai